Quality of life improvements in patients with PsA who achieve remission or low disease activity targets: results from two clinical trials of ixekizumab at three years of treatment
| Main Authors: | , , , , , , |
|---|---|
| Format: | Conference item |
| Language: | English |
| Published: |
Oxford University Press
2021
|
| _version_ | 1826302314109992960 |
|---|---|
| author | Coates, LC Birt, J Kronbergs, A Bolce, R Bradley, AJ Park, SY Helliwell, PS |
| author_facet | Coates, LC Birt, J Kronbergs, A Bolce, R Bradley, AJ Park, SY Helliwell, PS |
| author_sort | Coates, LC |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T05:45:41Z |
| format | Conference item |
| id | oxford-uuid:e7239357-742f-4ed7-9e38-76f0dbad1016 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T05:45:41Z |
| publishDate | 2021 |
| publisher | Oxford University Press |
| record_format | dspace |
| spelling | oxford-uuid:e7239357-742f-4ed7-9e38-76f0dbad10162022-03-27T10:36:19ZQuality of life improvements in patients with PsA who achieve remission or low disease activity targets: results from two clinical trials of ixekizumab at three years of treatmentConference itemhttp://purl.org/coar/resource_type/c_c94fuuid:e7239357-742f-4ed7-9e38-76f0dbad1016EnglishSymplectic ElementsOxford University Press2021Coates, LCBirt, JKronbergs, ABolce, RBradley, AJPark, SYHelliwell, PS |
| spellingShingle | Coates, LC Birt, J Kronbergs, A Bolce, R Bradley, AJ Park, SY Helliwell, PS Quality of life improvements in patients with PsA who achieve remission or low disease activity targets: results from two clinical trials of ixekizumab at three years of treatment |
| title | Quality of life improvements in patients with PsA who achieve remission or low disease activity targets: results from two clinical trials of ixekizumab at three years of treatment |
| title_full | Quality of life improvements in patients with PsA who achieve remission or low disease activity targets: results from two clinical trials of ixekizumab at three years of treatment |
| title_fullStr | Quality of life improvements in patients with PsA who achieve remission or low disease activity targets: results from two clinical trials of ixekizumab at three years of treatment |
| title_full_unstemmed | Quality of life improvements in patients with PsA who achieve remission or low disease activity targets: results from two clinical trials of ixekizumab at three years of treatment |
| title_short | Quality of life improvements in patients with PsA who achieve remission or low disease activity targets: results from two clinical trials of ixekizumab at three years of treatment |
| title_sort | quality of life improvements in patients with psa who achieve remission or low disease activity targets results from two clinical trials of ixekizumab at three years of treatment |
| work_keys_str_mv | AT coateslc qualityoflifeimprovementsinpatientswithpsawhoachieveremissionorlowdiseaseactivitytargetsresultsfromtwoclinicaltrialsofixekizumabatthreeyearsoftreatment AT birtj qualityoflifeimprovementsinpatientswithpsawhoachieveremissionorlowdiseaseactivitytargetsresultsfromtwoclinicaltrialsofixekizumabatthreeyearsoftreatment AT kronbergsa qualityoflifeimprovementsinpatientswithpsawhoachieveremissionorlowdiseaseactivitytargetsresultsfromtwoclinicaltrialsofixekizumabatthreeyearsoftreatment AT bolcer qualityoflifeimprovementsinpatientswithpsawhoachieveremissionorlowdiseaseactivitytargetsresultsfromtwoclinicaltrialsofixekizumabatthreeyearsoftreatment AT bradleyaj qualityoflifeimprovementsinpatientswithpsawhoachieveremissionorlowdiseaseactivitytargetsresultsfromtwoclinicaltrialsofixekizumabatthreeyearsoftreatment AT parksy qualityoflifeimprovementsinpatientswithpsawhoachieveremissionorlowdiseaseactivitytargetsresultsfromtwoclinicaltrialsofixekizumabatthreeyearsoftreatment AT helliwellps qualityoflifeimprovementsinpatientswithpsawhoachieveremissionorlowdiseaseactivitytargetsresultsfromtwoclinicaltrialsofixekizumabatthreeyearsoftreatment |